Radiopharmaceutical Theranostics Market Size And Share

  • Report Code : TIPRE00024328
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 185
Buy Now

Radiopharmaceutical Theranostics Market Size, Share, and Forecast by 2028

Buy Now

Radiopharmaceutical Theranostics Market: Strategic Insights

Radiopharmaceutical Theranostics Market

  • CAGR (2022 - 2028)
    11.3%
  • Market Size 2022
    US$ 1.81 Billion
  • Market Size 2028
    US$ 3.44 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising prevalence of cancer and other chronic diseases drives demand for targeted radiopharmaceutical therapies.
  • Technological advancements in imaging and therapy techniques enhance the efficacy of theranostic approaches.
  • Growing emphasis on personalized medicine promotes the adoption of radiopharmaceutical theranostics.
FUTURE TRENDS
  • Growing focus on integrating radiopharmaceuticals with advanced imaging technologies for improved diagnostic accuracy.
  • increased emphasis on developing novel theranostic agents tailored to specific patient profiles and tumor types.
  • Advancements in regulatory frameworks for radiopharmaceuticals may streamline approval processes and market entry.
OPPORTUNITIES
  • Expansion of research and development activities in radiopharmaceuticals offers significant growth potential.
  • Increasing collaboration between pharmaceutical companies and research institutions can accelerate product development.
  • Opportunities for novel combinations of imaging agents and therapeutic radiopharmaceuticals to enhance treatment outcomes.

Key Players

  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging Inc
  • Telix Pharmaceuticals Ltd
  • Cardinal Health Inc
  • Advanced Accelerator Applications S A
  • Jubilant Radiopharma
  • Theragnostics

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product Type
  • Alpha Emitters
  • Beta Emitters
  • Positron Emission Tomography Tracers
Radioisotope
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • 18F
  • Y-90
  • Lutetium 177
  • Copper 67
  • Copper 64
Source
  • Nuclear Reactors
  • Cyclotrons
Application
  • Targeted Therapeutic
  • Companion Diagnostic